Neuroleptic malignant syndrome: treatments, associated drugs and conditions

Summary:

Neuroleptic malignant syndrome: a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents.

We study 15,573 people who have Neuroleptic malignant syndrome. The information that eHealthMe analyzes includes:

- Medications that treat Neuroleptic malignant syndrome and their effectiveness
- 551 drugs that are associated with Neuroleptic malignant syndrome



Number of reports submitted per year:

Neuroleptic malignant syndrome: 15,573 reports.

All the drugs that are associated with Neuroleptic malignant syndrome:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: